Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

On Location

Updates from major medical meetings in the field of hematology/oncology
Understanding the Prognostic Impact of TP53 Mutations in Chronic Lymphocytic Leukemia
Lara C. Pullen, PhD
Mosunetuzumab Therapy Elicits High, Durable Responses in Patients With Follicular Lymphoma
Anna Azvolinsky, PhD
ATRA-ATO Regimen Demonstrates Superior EFS in Newly Diagnosed, High-Risk Acute Promyelocytic Leukemia
Khylia Marshall
Phase II CAPTIVATE Study: The 5.5-Year Update
Lara C. Pullen, PhD
Safety of Oral Azacytidine in Patients With Lower-Risk MDS Consistent With Prior Results
Anna Azvolinsky, PhD
Venetoclax May Increase Toxicity But Not Efficacy When Added to R-CHOP in Double-Expressor DLBCL
Katie Robinson
Study Identifies Characteristics Related to Bispecific Antibody Response, Resistance
Leah Lawrence
Addition of Avatrombopag to Cyclosporine Can Improve Response Rate in Elderly Patients with Transfusion-Dependent, Non-Severe Aplastic Anemia
Anna Azvolinsky, PhD
Patients With Functional High-Risk Multiple Myeloma Show High Response With Ide-Cel
Lara C. Pullen, PhD
Adenine Base Editors Could Offer Alternative Approach in Beta Hemoglobinopathies Gene Therapies
Ruth Jessen Hickman, MD
Quad Regimen Reduces Risk of Progression, Death in Older Patients with NDMM
Khylia Marshall
Survival Benefit Remains Unclear for Upfront AlloHCT in Untreated Aggressive ATL
Katie Robinson
Fewer Patients With CLL/SLL Switch From Zanubrutinib to Another BTKi
Ruth Jessen Hickman, MD
Teclistamab Combination with Daratumumab, Lenalidomide Shows Promising Efficacy, Tolerability in Patients with NDMM
Anna Azvolinsky, PhD
Rituximab Maintenance in MCL Found Advantageous After Firstline Treatment With Bendamustine-Rituximab
Thomas R. Collins
Phase I Study Shows Long-Term Efficacy of GPRC5D-Directed CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma
Katie Robinson
CARTITUDE-2 Cohort D: Cilta-Cel ± Len Effective for Multiple Myeloma
Lara C. Pullen, PhD
Bispecific Antibodies Potent Bridging Therapy to CAR T-Cell Therapy for R/R MM
Leah Lawrence
Machine Learning Outperforms Full Blood Count in Iron Deficiency Screening
Thomas R. Collins
Patients With Low-Grade NHL Experience High Rates of Mental Health Conditions
Ruth Jessen Hickman, MD

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
Mid-November 2024

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals